Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in Egypt / NCT06786715
Active, not recruiting Not applicable

Retrograde Intrarenal Surgery (RIRS) With Suction

NCT06786715 · tracked via the Priya Life Science Egypt tracker
Sponsor
Kafrelsheikh University
Phase
Not applicable
Started
2025-01-01
Last updated
2025-01-22

Condition(s) studied

Renal Stone

Investigational drug(s) / intervention(s)

Retrograde intrarenal surgery using DISSRetrograde intrarenal surgery using FANS

Retrograde intrarenal surgery using DISS: Retrograde intrarenal surgery using Direct in scope suction for renal stone up to 3 cm

Retrograde intrarenal surgery using FANS: Retrograde intrarenal surgery using Flexible and navigable suction for renal stone up to 3 cm

Study summary

Suction has been initially used in endoscopic stone management for more than 25 years during PCNL, but the emergence of new devices applying suction through patented ureteroscopes, ureteral access sheaths (UAS) and ureteral catheters led to application of suction in URS/RIRS. The application of ureteral access sheath (UAS) in RIRS can improve surgical vision , reduce intrarenal pressure (IRP) ,and decrease postoperative infectious complications .

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Single stone * Medium sized stone ≤ 3 cm * Renal stone * age group \> 18 Exclusion Criteria: * multiple renal stones * stone size \> 3 cm * age group \< 18 * solitary kidney * Obstruction distal to the stone. * urinary tract infection

Primary outcome measure(s)

  • Stone free rate — One month
    No residual or non siginficant residual less than 4 mm

Trial sites (1)

FacilityCityRegionStatus
Elsayed Abdelhalim Zagazig Egypt

More Kafrelsheikh University trials in Egypt

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty Recruiting
the Impact of Physical and Mental Fatigue on Balance Starting soon
Comparison the Effect of Smart Phones Addiction Between Children and Adolescents on Posture Deviations , Physical Fitness and Intelligence in Egypt Recruiting
Comparison of Laparoscopic and Open Total Mesocolic Excision With Central Vascular Ligation for Right Colon Carcinoma Starting soon
Acetyl-leucine in Post-stroke Ataxia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06786715 on ClinicalTrials.gov ↗ ← All trials in Egypt